Skip to main content

Published locations for FDA expands rimegepant indication to include migraine prevention

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands rimegepant indication to include migraine prevention

User login

  • Reset your password
  • /content/fda-expands-rimegepant-indication-include-migraine-prevention
  • /neurologyreviews/article/240939/headache-migraine/fda-expands-rimegepant-indication-include-migraine
  • /jcomjournal/article/240939/headache-migraine/fda-expands-rimegepant-indication-include-migraine
  • /migraine-icymi/article/240939/headache-migraine/fda-expands-rimegepant-indication-include-migraine
  • /neurology/article/240939/headache-migraine/fda-expands-rimegepant-indication-include-migraine
  • /breast-cancer-icymi/article/240939/headache-migraine/fda-expands-rimegepant-indication-include
  • /b-cell-lymphoma-icymi/article/240939/headache-migraine/fda-expands-rimegepant-indication-include